Quality of life in multiple sclerosis: the impact of depression, fatigue and disability
Top Cited Papers
- 1 October 2001
- journal article
- research article
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 7 (5), 340-344
- https://doi.org/10.1177/135245850100700511
Abstract
This study deals with the assessment of quality of life and its main clinical and demographical determinants in a clinical series of 103 patients with multiple sclerosis (MS) (37 men; 66 women; mean age 44.89 years; mean disease duration 12.40 years; mean EDSS score 4.07). We used the MSQOL-54 inventory, a disease-specific instrument recently validated in an Italian population. Each patient underwent a complete clinical assessment, including that of disability status (Expanded Disability Status Scale), cognitive function (Mini Mental State Examination), depression (Hamilton Rating Scale for Depression) and fatigue (Fatigue Severity Scale). In terms of Pearson's correlations, there was a moderate inverse relationship between disability level and the MSQOL-54 physical composite score, and a moderate to strong inverse correlation between depression or fatigue severity and both the physical and mental composite scores. In a stepwise linear regression analysis, depression, fatigue and disability level were confirmed to be significant and independent predictors of quality of life. Quality of life instruments can help to provide a broader measure of the disease impact and to develop a care program tailored to the patient's needs.Keywords
This publication has 39 references indexed in Scilit:
- Multiple sclerosis, disease modifying treatments and depression: a critical methodological reviewMultiple Sclerosis Journal, 2000
- Fatigue in multiple sclerosis and its relationship to depression and neurologic disabilityMultiple Sclerosis Journal, 2000
- Fatigue in multiple sclerosis: relationship to depression, disability, and disease patternMultiple Sclerosis Journal, 2000
- Type I interferons and the quality of life of multiple sclerosis patients. Results from a clinical trial on interferon alfa-2aMultiple Sclerosis Journal, 1999
- Quantification of impairment in MS: discussion of the scales in useMultiple Sclerosis Journal, 1999
- Quality of Life Among Persons with Multiple Sclerosis and their CaregiversNeurology, 1997
- Defining the clinical course of multiple sclerosisNeurology, 1996
- The MOS 36-Item Short-Form Health Survey (SF-36)Medical Care, 1993
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983